Real Life Effectiveness in Patients With Not Optimally Controlled Asthma

Far Eastern Memorial Hospital

Status and phase: Completed; Phase 4

Conditions: Asthma

Treatments: Drug: Seretide

Study type: Interventional

Funder types: Other

Identifiers

NCT01647646

97083

Details and patient eligibility

About

In real life, the investigators will be using different strategies including SMART therapy or other ICS/LABA (medium and high dose) therapy and measure the efficacy for asthma control.

Full description

1. All not-well controlled asthma patients would include the study.
2. We will compare three ways of asthma control including SMART, fixed doses with regular doses and fixed doses with higher doses
3. We will evaluate the efficacy/safety for these not-well controlled patients.

Enrollment: 200 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• asthma not well control

Exclusion criteria

• COPD

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

200 participants in 2 patient groups

Symbicort

Active Comparator group

Description:

We will evaluate the efficacy fot Symbicort use. The usage was 2 doses bid for one year period. Intervention drug: Seretide fixed doses therapy

Treatment:

Drug: Seretide

Seretide

Experimental group

Description:

In non-well asthma controlled patients, experimental study with Seretide regular doses (125 2 doses bid for one year) and higher doses (250 2 doses bid) for one year

Treatment:

Drug: Seretide